XXXX for the treatment of gram-positive @entity293 .

@entity1 @entity295 @entity114 @entity794 @entity793 @entity3524 @entity797 @entity56 @entity99 @entity2259 @entity293
@entity293 ( @entity293 ) due to gram-positive bacteria are fairly uncommon. In order to investigate the efficacy of treatment for @entity293 secondary to gram-positive rods, we performed a non-comparative study on the effect of @entity3524 in 64 @entity1 with gram-positive @entity293 . @entity1 with a history of @entity56 to cephalosporins and @entity114 as well as @entity1 who had received antibiotic treatment within 48 hours after the administration of @entity3524 , @entity1 with @entity99 and @entity1 with fatal progressive disease were excluded from the study. @entity293 was confirmed by positive cultures with a colony count of greater than or equal to 100,000 cfu/ml of gram-positive organisms before treatment with @entity3524 . When @entity295 or @entity793 occurred after two days of hospitalization, the @entity293 was considered nosocomial. The most common microorganism isolated was @entity794 , followed by @entity797 . 30% of the @entity1 showed polymicrobic @entity793 , especially in association with gram-negative bacteria (70%). A high frequency of predisposing factors was present in the urinary tract, mainly obstruction, indwelling catheters, surgery and chronic debilitating diseases. Seven @entity1 developed @entity2259 . All @entity1 were treated with @entity3524 i.m. or i.v. at a daily dosage ranging between 4 and 12 g. Urine cultures were repeated five days after the beginning of treatment and again two to three weeks after the end.(ABSTRACT TRUNCATED AT 250 WORDS)
